← Back to DNLI

Denali Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 06/05/2025
$3.6$0$0$0$0
−$128−$128−$127−$124−$133−$107−$99−$102
−$0.68−$0.69−$0.74−$0.72−$0.78−$0.63−$0.59−$0.68
187187172171171169169149

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.